Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(23):1795; doi:10.1093/jnci/djh342
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Tsurutani, J.
Right arrow Articles by Dennis, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsurutani, J.
Right arrow Articles by Dennis, P. A.
Related Collections
Right arrowResponse to this Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

CORRESPONDENCE

Re: Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non–Small-Cell Lung Cancer

Junji Tsurutani, Phillip A. Dennis

Affiliation of authors: Cancer Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD

Correspondence to: Phillip A. Dennis, MD, PhD, Cancer Therapeutics Branch, National Cancer Institute, National Institutes of Health, 8901 Wisconsin Ave., Bldg. 8, Rm. 5101, Bethesda, MD 20889 (e-mail: dennisp@mail.nih.gov)

The first 10% of the full text of this article appears below.

In a recent article in the Journal, Cappuzzo et al. (1) presented data that Akt activation, as assessed by the phosphorylation status of S473 (pAkt), was associated with sensitivity to gefitinib in patients with non–small-cell lung cancer (NSCLC). Patients whose . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Response to this Correspondence

RESPONSE: Re: Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non–Small-Cell Lung Cancer
Federico Cappuzzo
J Natl Cancer Inst 2004 96: 1795-1796. [Extract] [Full Text] [PDF]